약물알레르기 검사의 시행과 해석: 전문가 의견서
KAAACI Standardization Committee Report on the procedures and applications of the diagnostic tests for drug allergy
1
조회
0
다운로드
8
인용
0
참고문헌
키워드
초록
Diagnostic methods for drug allergy include the patient’s history, in vivo skin test, in vitro laboratory test, and provocation test. However, the history is often not reliable, procedures for in vivo and in vitro tests are not standardized, and provocation tests are sometimes harmful to patients. Generally, skin prick and intradermal tests are useful for immediate reactions; in contrast, patch test and delayed reading of both skin prick and intradermal tests are helpful for delayed reactions. A drug provocation test is the gold standard for both responses, and it is necessary to be aware of exact indications and contraindications with appropriate drugs, doses, and intervals. To date, several methods have been developed to detect culprit agents for drug hypersensitivity reactions, but they are neither completely well validated nor standardized. Based on this awareness and necessity, the Korean Academy of Asthma, Allergy and Clinical Immunology launched the Standardization Committee to review the international guidelines and the literature, and then developed the consensus report on the procedures and applications of diagnostic tests for drug allergy.
Abstract
Diagnostic methods for drug allergy include the patient’s history, in vivo skin test, in vitro laboratory test, and provocation test. However, the history is often not reliable, procedures for in vivo and in vitro tests are not standardized, and provocation tests are sometimes harmful to patients. Generally, skin prick and intradermal tests are useful for immediate reactions; in contrast, patch test and delayed reading of both skin prick and intradermal tests are helpful for delayed reactions. A drug provocation test is the gold standard for both responses, and it is necessary to be aware of exact indications and contraindications with appropriate drugs, doses, and intervals. To date, several methods have been developed to detect culprit agents for drug hypersensitivity reactions, but they are neither completely well validated nor standardized. Based on this awareness and necessity, the Korean Academy of Asthma, Allergy and Clinical Immunology launched the Standardization Committee to review the international guidelines and the literature, and then developed the consensus report on the procedures and applications of diagnostic tests for drug allergy.
참고문헌 (38)
- "International drug monitoring: the role of national centres. Report of a WHO meeting", World Health Organ Tech Rep Ser, 498, pp.1~25 (1972)
- Joint Task Force on Practice Parameters, "Drug allergy: an updated practice parameter", Ann Allergy Asthma Immunol, 105, pp.259~273 (2010)
- Barbaud A, "Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions", Contact Dermatitis, 45, pp.321~328 (2001)
- Brockow K, "General considerations for skin test procedures in the diagnosis of drug hypersensitivity", Allergy, 57, pp.45~51 (2002)
- Aberer W, "Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations", Allergy, 58, pp.854~863 (2003)
- Johansen JD, "European Society of Contact Dermatitis guideline for diagnostic patch testing - recommendations on best practice", Contact Dermatitis, 73, pp.195~221 (2015)
- Brockow K, "Skin test concentrations for systemically administered drugs -- an ENDA", EAACI Drug Allergy Interest Group position paper, 2013, pp.68, 702~712
- Cho YJ, "Guideline for antibiotic skin test - for immediate hypersensitivity reaction" (2012), Medrang
- Torres MJ, "Diagnosis of immediate allergic reactions to beta-lactam antibiotics", Allergy, 58, pp.961~972 (2003)
- Mangodt EA, "In vitro diagnosis of immediate drug hypersensitivity: should we go with the flow", Int Arch Allergy Immunol, 168, pp.3~12 (2015)
- Kränke B, "Skin testing for IgE-mediated drug allergy", Immunol Allergy Clin North Am, 29, pp.503~516 (2009)
- Won HK, "Determination of nonirritating concentrations of antibiotics for intradermal skin tests in Korean adults", J Allergy Clin Immunol Pract, 5, pp.192~194 (2017)
- Alanko K, "Topical provocation of fixed drug eruption. A study of 30 patients", Contact Dermatitis, 31, pp.25~27 (1994)
- Ozkaya-Bayazit E, "Topical provocation in 27 cases of cotrimoxazole-induced fixed drug eruption", Contact Dermatitis, 41, pp.185~189 (1999)
- Brajon D, "Non-irritant concentrations and amounts of active ingredient in drug patch tests", Contact Dermatitis, 71, pp.170~175 (2014)
- Brockow K, "Skin tests in the diagnosis of drug hypersensitivity reactions", Curr Pharm Des, 14, pp.2778~2791 (2008)
- Nugent JS, "Determination of the incidence of sensitization after penicillin skin testing", Ann Allergy Asthma Immunol, 90, pp.398~403 (2003)
- Aberer W, "Provocation tests in drug hypersensitivity", Immunol Allergy Clin North Am, 29, pp.567~584 (2009)
- Joint Task Force on Practice Parameters, "Executive summary of disease management of drug hypersensitivity: a practice parameter", Ann Allergy Asthma Immunol, 83(6 Pt 3), pp.665~700 (1999)
- 김윤정, "Cross-reactivity to Acetaminophen and Celecoxib According to the Type of Nonsteroidal Anti-inflammatory Drug Hypersensitivity", Allergy, Asthma & Immunology Research, 6(2), pp.156~162 (2014), 대한천식알레르기학회
- Hye Ran Na, "Usefulness of drug provocation tests in children with a history of adverse drug reaction", Korean Journal of Pediatrics, 54(7), pp.304~309 (2011), 대한소아과학회
- 허규영, "Oral Muscle Relaxant May Induce Immediate Allergic Reactions", Yonsei Medical Journal, 53(4), pp.863~865 (2012), 연세대학교의과대학[DOI]
- Reidenberg MM, "Adverse nondrug reactions", N Engl J Med, 279, pp.678~679 (1968)
- Chiriac AM, "Drug provocation tests: up-date and novel approaches", Allergy Asthma Clin Immunol, 9, pp.12~ (2013)
- Demoly P, "Determining the negative predictive value of provocation tests with beta-lactams", Allergy, 65, pp.327~332 (2010)
- Blanca M, "Clinical evaluation of Pharmacia CAP System RAST FEIA amoxicilloyl and benzylpenicilloyl in patients with penicillin allergy", Allergy, 56, pp.862~870 (2001)
- Sanz ML, "Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate-type reactions to betalactam antibiotics", Clin Exp Allergy, 32, pp.277~286 (2002)
- Blanca M, "Update on the evaluation of hypersensitivity reactions to betalactams", Allergy, 64, pp.183~193 (2009)
- Ayuso P, "Advanced phenotyping in hypersensitivity drug reactions to NSAIDs", Clin Exp Allergy, 43, pp.1097~1109 (2013)
- Duy Le Pham, "What we know about nonsteroidal anti-inflammatory drug hypersensitivity", The Korean Journal of Internal Medicine, 31(3), pp.417~432 (2016), 대한내과학회
- 장헌수, "Diagnostic Value of Clinical Parameters in the Prediction of Aspirin-Exacerbated Respiratory Disease in Asthma", Allergy, Asthma & Immunology Research, 3(4), pp.256~264 (2011), 대한천식알레르기학회
- Bochenek G, "Aspirin-exacerbated respiratory disease: clinical disease and diagnosis", Immunol Allergy Clin North Am, 33, pp.147~161 (2013)
- Nizankowska-Mogilnicka E, "EAACI", GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity, 2007, pp.62, 1111~1118
- Blanca-Lopez N, "Value of the clinical history in the diagnosis of urticaria", angioedema induced by NSAIDs with cross-intolerance, 2013, pp.43, 85~91
- Purevsuren Losol, "Molecular Genetic Mechanisms of Chronic Urticaria", Allergy, Asthma & Immunology Research, 6(1), pp.13~21 (2014), 대한천식알레르기학회
- Knowles SR, "Management options for patients with aspirin and nonsteroidal antiinflammatory drug sensitivity", Ann Pharmacother, 41, pp.1191~1200 (2007)
- Himly M, "IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone", J Allergy Clin Immunol, 111, pp.882~888 (2003)
- Woessner KM, "NSAID single-drug-induced reactions", Immunol Allergy Clin North Am, 33, pp.237~249 (2013)